Takeda Pharmaceutical (TAK) P/E (2010 - 2026)
Takeda Pharmaceutical (TAK) P/E from Mar 31, 2010 to Jul 21, 2026. The TTM Takeda Pharmaceutical (TAK) P/E is 42.41. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Takeda Pharmaceutical (TAK)
| Year | P/E | Change |
|---|---|---|
| 2026 | 42.41 | -35.09% |
| 2025 | 65.34 | +110.60% |
| 2024 | 31.03 | -0.60% |
| 2023 | 31.21 | +3.07% |
| 2022 | 30.28 | +178.67% |
| 2021 | 10.87 | -67.46% |
| 2020 | 33.40 | -126.34% |
| 2019 | -126.80 | -561.73% |
| 2018 | 27.46 | -11.92% |
| 2017 | 31.18 | -21.13% |
| 2016 | 39.53 | -147.13% |
| 2015 | -83.87 | -189.77% |
| 2014 | 93.43 | +50.53% |
| 2013 | 62.07 | +15.01% |
| 2012 | 53.97 | +133.01% |
| 2011 | 23.16 | -9.75% |
| 2010 | 25.66 | N/A |
Comparison Takeda Pharmaceutical (TAK) P/E with competitors
Takeda Pharmaceutical (TAK) P/E is 42.41.